Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials
Effective implementation of cancer screening programs can reduce disease-specific incidence and mortality. Screening is currently recommended for breast, cervical, colorectal and lung cancer. However, initial and repeat adherence to screening tests in accordance with current guidelines is sub-optima...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-02-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1307459/full |
| _version_ | 1827338956490932224 |
|---|---|
| author | Cheryl L. Thompson Adam H. Buchanan Ronald Myers David S. Weinberg |
| author_facet | Cheryl L. Thompson Adam H. Buchanan Ronald Myers David S. Weinberg |
| author_sort | Cheryl L. Thompson |
| collection | DOAJ |
| description | Effective implementation of cancer screening programs can reduce disease-specific incidence and mortality. Screening is currently recommended for breast, cervical, colorectal and lung cancer. However, initial and repeat adherence to screening tests in accordance with current guidelines is sub-optimal, with the lowest rates observed in historically underserved groups. If used in concert with recommended cancer screening tests, new biospecimen-based multi-cancer early detection (MCED) tests could help to identify more cancers that may be amendable to effective treatment. Clinical trials designed to assess the safety and efficacy of MCED tests to assess their potential for reducing cancer mortality are needed and many are underway. In the conduct of MCED test trials, it is crucial that participant recruitment efforts successfully engage participants from diverse populations experiencing cancer disparities. Strategic partnerships involving health systems, clinical practices, and communities can increase the reach of MCED trial recruitment efforts among populations experiencing disparities. This goal can be achieved by developing health system-based learning communities that build understanding of and trust in biomedical research; and by applying innovative methods for identifying eligible trial patients, educating potential participants about research trials, and engaging eligible individuals in shared decision making (SDM) about trial participation. This article describes how a developing consortium of health systems has used this approach to encourage the uptake of cancer screening in a wide range of populations and how such a strategy can facilitate the enrollment of persons from diverse patient and community populations in MCED trials. |
| first_indexed | 2024-03-07T19:43:06Z |
| format | Article |
| id | doaj.art-024ee4e835e64ef5a7df84b6d75fcfa1 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-03-07T19:43:06Z |
| publishDate | 2024-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-024ee4e835e64ef5a7df84b6d75fcfa12024-02-29T04:59:10ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-02-011310.3389/fonc.2023.13074591307459Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trialsCheryl L. Thompson0Adam H. Buchanan1Ronald Myers2David S. Weinberg3Penn State Cancer Institute, Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, United StatesDepartment of Genomic Health, Geisinger, Danville, PA, United StatesDivision of Population Science Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, United StatesDepartment of Medicine, Fox Chase Cancer Center, Philadelphia, PA, United StatesEffective implementation of cancer screening programs can reduce disease-specific incidence and mortality. Screening is currently recommended for breast, cervical, colorectal and lung cancer. However, initial and repeat adherence to screening tests in accordance with current guidelines is sub-optimal, with the lowest rates observed in historically underserved groups. If used in concert with recommended cancer screening tests, new biospecimen-based multi-cancer early detection (MCED) tests could help to identify more cancers that may be amendable to effective treatment. Clinical trials designed to assess the safety and efficacy of MCED tests to assess their potential for reducing cancer mortality are needed and many are underway. In the conduct of MCED test trials, it is crucial that participant recruitment efforts successfully engage participants from diverse populations experiencing cancer disparities. Strategic partnerships involving health systems, clinical practices, and communities can increase the reach of MCED trial recruitment efforts among populations experiencing disparities. This goal can be achieved by developing health system-based learning communities that build understanding of and trust in biomedical research; and by applying innovative methods for identifying eligible trial patients, educating potential participants about research trials, and engaging eligible individuals in shared decision making (SDM) about trial participation. This article describes how a developing consortium of health systems has used this approach to encourage the uptake of cancer screening in a wide range of populations and how such a strategy can facilitate the enrollment of persons from diverse patient and community populations in MCED trials.https://www.frontiersin.org/articles/10.3389/fonc.2023.1307459/fullmulti-cancer detection assaysprimary careshared decision makingcommunity engagementcancerscreening |
| spellingShingle | Cheryl L. Thompson Adam H. Buchanan Ronald Myers David S. Weinberg Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials Frontiers in Oncology multi-cancer detection assays primary care shared decision making community engagement cancer screening |
| title | Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials |
| title_full | Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials |
| title_fullStr | Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials |
| title_full_unstemmed | Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials |
| title_short | Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials |
| title_sort | integrating primary care shared decision making and community engagement to facilitate equitable access to multi cancer early detection clinical trials |
| topic | multi-cancer detection assays primary care shared decision making community engagement cancer screening |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1307459/full |
| work_keys_str_mv | AT cheryllthompson integratingprimarycareshareddecisionmakingandcommunityengagementtofacilitateequitableaccesstomulticancerearlydetectionclinicaltrials AT adamhbuchanan integratingprimarycareshareddecisionmakingandcommunityengagementtofacilitateequitableaccesstomulticancerearlydetectionclinicaltrials AT ronaldmyers integratingprimarycareshareddecisionmakingandcommunityengagementtofacilitateequitableaccesstomulticancerearlydetectionclinicaltrials AT davidsweinberg integratingprimarycareshareddecisionmakingandcommunityengagementtofacilitateequitableaccesstomulticancerearlydetectionclinicaltrials |